Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

John H. Krystal · Archives of General Psychiatry · 1994 · 3.3K citations

Medicine, Neuroscience, Pharmacology +13

Strychnine Binding Associated with Glycine Receptors of the Central Nervous System

Anne B. Young, Solomon H. Snyder · Proceedings of the National Academy of Sciences · 1973 · 389 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia

Guochuan Tsai, Hsien‐Yuan Lane, Pinchen Yang et al. · Biological Psychiatry · 2004 · 344 citations

Medicine, Pharmacology, Psychiatry +12

Sarcosine or D-Serine Add-on Treatment for Acute Exacerbation of Schizophrenia

Hsien‐Yuan Lane, Yue‐Cune Chang, Yi‐Ching Liu et al. · Archives of General Psychiatry · 2005 · 271 citations

Medicine, Pharmacotherapy, Psychiatry +17

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 261 citations

Medicine, Neuroscience, Pharmacology +13